Researchers show that genetic analysis of colorectal polyps can uncover cancer predisposition missed by blood-based testing.
Tempest Therapeutics, Inc. has announced that the FDA has granted Orphan Drug Designation to its dual receptor inhibitor TPST-1495 for treating Familial Adenomatous Polyposis (FAP), a rare genetic ...
For 10% of colorectal cancer patients, hereditary factors play a role, with higher percentages among younger patients.
Biodexa Pharmaceuticals PLC has filed a Clinical Trial Application (CTA) with the European Medicines Agency (EMA) for its Phase 3 Serenta trial, aimed at patients with familial adenomatous polyposis ...
Researchers have discovered an unusual case where two well-known cancer-related mutations—APC and KRAS—coexisted in a woman with familial adenomatous polyposis (FAP) and a history of endometrial ...
Researchers from Tel Aviv University and Tel Aviv Sourasky Medical Center (Ichilov Hospital) have developed an innovative drug treatment for familial adenomatous polyposis (FAP), a rare, inherited ...
Researchers have developed an innovative drug treatment for familial adenomatous polyposis (FAP), a rare, inherited condition that affects adolescents and young adults and often leads to colorectal ...
AI can increase adenoma detection rates by 10-15%, enhancing colonoscopy effectiveness in reducing colorectal cancer risk. Higher adenoma detection rates correlate with lower interval colorectal ...
Colorectal cancer (CRC) is a leading global health burden, ranking as the third most common malignancy and the second most deadly cancer worldwide. While bacterial dysbiosis in the gut has long been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results